- Patients
- Clinical Research
- Clinical trials
- Ariceum
2023-08-02T00:00:00.000+10:00
Ongoing
Ariceum
Ariceum
Lung cancer
A multicentre, open-label, phase Ia/Ib study investigating the safety, tolerability and efficacy of 177Lu-SSO110 with companion imaging 68Ga-SSO120 in participants with extensive stage Small Cell Lung Cancer who are on maintenance treatment with Atezolizumab (Ariceum SSO110-01)
A multicentre, open-label, phase Ia/Ib study investigating the safety, tolerability and efficacy of 177Lu-SSO110 with companion imaging 68Ga-SSO120 in participants with extensive stage Small Cell Lung Cancer who are on maintenance treatment with Atezolizumab (Ariceum SSO110-01)
Trial overview
Clinical Area
Theranostics
Disease / Condition
Lung
Study Phase
I
Trial Identifiers
Registration number: ACTRN12623000185662
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385299&isReview=true
GenesisCare Location(s)
GenesisCare Murdoch
:::
Principal Investigator(s)